“Strong” = several concordant meta-analyses or systematic reviews. “Moderate” = one synthesis, or several controlled trials. “Limited” = early trials only. The rating is about the quality of the studies, not about how useful the supplement is.
Spice studied primarily in type 2 diabetics: it lowers fasting blood glucose in several meta-analyses, with a less consistent effect on glycated hemoglobin. Cassia cinnamon contains coumarin.
If you are taking antidiabetic medications, talk to your doctor: in the trials, cinnamon was added to usual treatments and lowered blood glucose on top of that. Cassia cinnamon contains up to 1% coumarin, and high consumption can exceed the tolerable daily intake: in 24 volunteers, the coumarin from cassia powder was absorbed almost as much as isolated coumarin (56% vs 62.8%), and even faster as an herbal tea. The most frequent side effects are digestive and allergic, most often transient; one review considers that at medicinal doses or over long periods they can become significant and require monitoring. In trial meta-analyses, they are no more frequent than under placebo; in the Ceylon cinnamon trial, 2 participants out of 30 stopped due to digestive disorders, with no liver damage or anticoagulant effect. Also worth noting: the effect on glycated hemoglobin is not consistent (nothing in the meta-analyses of 10 and 16 trials), the trials use very different preparations and doses, with high heterogeneity, and in polycystic ovary syndrome cinnamon changed neither weight nor androgens.
1 to 2 g of cinnamon per day in diabetes trials (from 120 mg to 6 g depending on the studies); 1.5 g per day in polycystic ovary syndrome.
In 24 volunteers, the coumarin from cinnamon drunk as an herbal tea passed into the blood the fastest, and in the same amount as pure coumarin in a capsule over eight hours (66.1% vs 62.8%).
This updated meta-analysis, based on 24 randomized clinical trials, evaluated the effects of cinnamon supplementation on glycemic control in patients with type 2 diabetes. The results showed that cinnamon led to a statistically significant reduction in fasting blood glucose, the HOMA-IR index (a marker of insulin resistance), and hemoglobin A1C. In contrast, it did not significantly alter serum insulin levels. These conclusions suggest that cinnamon may have clinical potential as an add-on therapy for the management of type 2 diabetes.
Moridpour AH, Kavyani Z, Khosravi S, Farmani E, Daneshvar M, Musazadeh V, Faghfouri AH. — Phytotherapy research : PTR (2024) — View the source study
For information only: not a substitute for medical advice. Dietary supplements are not a replacement for a varied, balanced diet. Learn more